<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/706543CE-9B05-46B6-A616-B6D6B332C5DC"><gtr:id>706543CE-9B05-46B6-A616-B6D6B332C5DC</gtr:id><gtr:firstName>Luiz Pedro</gtr:firstName><gtr:surname>Carvalho</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UP_A253_1111"><gtr:id>83F558A5-704C-4415-859B-9DDF23B963A7</gtr:id><gtr:title>Mycobacterium tuberculosis Systems and Chemical Biology</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UP_A253_1111</gtr:grantReference><gtr:abstractText>We aim to identify and characterize metabolic components from Mycobacterium tuberculosis responsible for its unique ability to survive in humans and cause disease. In addition, we are interested in understanding how antibiotics act against M. tuberculosis, how is resistance developed and how we can discover novel antibiotics that are better than the ones in current use.
Enzymes are responsible for most of the activities in any cell, from bacteria to man. We are particularly interested in novel enzymes from M. tuberculosis that must participate in novel metabolic pathways. In addition, some of these essential enzymes will lack counterparts in humans and therefore might represent attractive new targets for antibiotic research.
We are very interested in discovering how M. tuberculosis survives in host, evades the immune system and resist to antibiotic therapy. To achieve this, we are using state-of-the-art approaches to integrate several aspects of M. tuberculosis?host biology.</gtr:abstractText><gtr:technicalSummary>The aim of our research is to uncover new physiology and new biochemistry that helps Mycobacterium tuberculosis to survive in the host and to avoid the immune system. In addition, we are committed with the characterization and development of novel anti-infectives to treat human Tuberculosis. Novel small molecule therapeutics for Tuberculosis could help save as many as 1.5 million lives yearly.
Our approach involves the use of enzymology, mycobacteriology, immunology, structural biology, chemical biology and accurate-mass LC-MS-based metabolomics.
Functional Genomics: To uncover new pathways and chemical reactions we are applying metabolomic and enzymology approaches to orphan mycobacterial enzymes, trying to determine their function and their contribution to mycobacterial metabolism and fitness. These experiments are further complemented by structural biology and mycobacterial genetics.
Drug Discovery: Mechanistic enzymology and metabolomics are also been used to characterize and validate and novel anti-infective targets in Mycobacterium tuberculosis and develop novel and better inhibitors. Mechanism-of-action and ?on-target? validation studies using metabolomics are underway. Selected inhibitors will be tested against mycobacteria to verify their potential as novel anti-infectives.
Systems Biology: Stable isotope labelling and metabolomics are employed to define the flux through known biochemical pathways and the role of these pathways in Mycobacterium tuberculosis survival in culture and in macrophages. In addition, isotope tracing methods are also been used to map new metabolic pathways in mycobacteria. Some of these pathways might represent attractive targets for the development of novel drugs. These experiments are further complemented by the use of small molecules and genetic mutants.</gtr:technicalSummary><gtr:fund><gtr:end>2015-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>2473715</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>61EA0E73-0127-497C-A430-DA50968CC70C</gtr:id><gtr:title>Kinetic mechanism and inhibition of Mycobacterium tuberculosis D-alanine:D-alanine ligase by the antibiotic D-cycloserine.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ff05717b116861ab443b2faae7f90a3"><gtr:id>7ff05717b116861ab443b2faae7f90a3</gtr:id><gtr:otherNames>Prosser GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>pm_14635_25_23286234</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF7BF58F-9F23-4000-B538-2E51FE1416A8</gtr:id><gtr:title>Two enzymes with redundant fructose bisphosphatase activity sustain gluconeogenesis and virulence in Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/356de905e3e7f89cc401afee4623fe32"><gtr:id>356de905e3e7f89cc401afee4623fe32</gtr:id><gtr:otherNames>Ganapathy U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5675ea0235356</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EB0E46D-A1AF-4E9B-B6F6-FAEDAFAFD883</gtr:id><gtr:title>Chemical mechanism of glycerol 3-phosphate phosphatase: pH-dependent changes in the rate-limiting step.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8986ac3fa3322233291fd59ae2805b6b"><gtr:id>8986ac3fa3322233291fd59ae2805b6b</gtr:id><gtr:otherNames>Larrouy-Maumus G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>doi_55f985985ff70293</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF9AA673-91A1-4A4C-995B-9346A94129E9</gtr:id><gtr:title>Mycobacterium tuberculosis exploits asparagine to assimilate nitrogen and resist acid stress during infection.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c78f759d92ee633ff031da9f74a236de"><gtr:id>c78f759d92ee633ff031da9f74a236de</gtr:id><gtr:otherNames>Gouzy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>doi_55f98698600a798f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D34B548B-77ED-4A79-9E61-B87F1C6A4FC6</gtr:id><gtr:title>Reinterpreting the mechanism of inhibition of Mycobacterium tuberculosis D-alanine:D-alanine ligase by D-cycloserine.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ff05717b116861ab443b2faae7f90a3"><gtr:id>7ff05717b116861ab443b2faae7f90a3</gtr:id><gtr:otherNames>Prosser GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>pm_14635_25_24033232</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>736DFC2F-72A3-4CB3-A91F-1BF972658AF6</gtr:id><gtr:title>Cell-Envelope Remodeling as a Determinant of Phenotypic Antibacterial Tolerance in.</gtr:title><gtr:parentPublicationTitle>ACS infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8986ac3fa3322233291fd59ae2805b6b"><gtr:id>8986ac3fa3322233291fd59ae2805b6b</gtr:id><gtr:otherNames>Larrouy-Maumus G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2373-8227</gtr:issn><gtr:outcomeId>585d364ebc8329.56565866</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79942B1B-D598-45F3-A611-7F7A8607E9ED</gtr:id><gtr:title>Functional assignment of Mycobacterium tuberculosis proteome revealed by genome-scale fold-recognition.</gtr:title><gtr:parentPublicationTitle>Tuberculosis (Edinburgh, Scotland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83d53858e81bcad6fcc9fc1d22a78b7a"><gtr:id>83d53858e81bcad6fcc9fc1d22a78b7a</gtr:id><gtr:otherNames>Mao C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1472-9792</gtr:issn><gtr:outcomeId>pm_14635_25_23287603</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8EEE7B21-076F-4242-B074-F65DB43E228B</gtr:id><gtr:title>Metabolomic strategies for the identification of new enzyme functions and metabolic pathways.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ff05717b116861ab443b2faae7f90a3"><gtr:id>7ff05717b116861ab443b2faae7f90a3</gtr:id><gtr:otherNames>Prosser GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn><gtr:outcomeId>doi_55f986986013fe62</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24FF7249-89EE-4C3B-B637-8A883D260D35</gtr:id><gtr:title>Discovery of a glycerol 3-phosphate phosphatase reveals glycerophospholipid polar head recycling in Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8986ac3fa3322233291fd59ae2805b6b"><gtr:id>8986ac3fa3322233291fd59ae2805b6b</gtr:id><gtr:otherNames>Larrouy-Maumus G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_14635_25_23801751</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69FC0319-8584-4D65-B527-3A10F9DD08CD</gtr:id><gtr:title>Mechanism of feedback allosteric inhibition of ATP phosphoribosyltransferase.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46757554c8f617653e8b0ce055403679"><gtr:id>46757554c8f617653e8b0ce055403679</gtr:id><gtr:otherNames>Pedre?o S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>pm_14635_25_22989207</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F24BF1B7-5299-4CBB-B80E-0E35993BC1E9</gtr:id><gtr:title>Metabolomics Reveal d-Alanine:d-Alanine Ligase As the Target of d-Cycloserine in</gtr:title><gtr:parentPublicationTitle>ACS medicinal chemistry letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ff05717b116861ab443b2faae7f90a3"><gtr:id>7ff05717b116861ab443b2faae7f90a3</gtr:id><gtr:otherNames>Prosser GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1948-5875</gtr:issn><gtr:outcomeId>doi_14635__ml400349n</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A71F20A-78E8-45EF-B69B-1F62C77D7151</gtr:id><gtr:title>Fragment-Based Approaches to the Development of Mycobacterium tuberculosis CYP121 Inhibitors.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/344824a04c019f2bb858bd4b3033c581"><gtr:id>344824a04c019f2bb858bd4b3033c581</gtr:id><gtr:otherNames>Kavanagh ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>585d51a4e7ae41.14520544</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F031D32-D24D-41AC-ACB5-78295A30083E</gtr:id><gtr:title>Mycobacterium tuberculosis nitrogen assimilation and host colonization require aspartate.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c78f759d92ee633ff031da9f74a236de"><gtr:id>c78f759d92ee633ff031da9f74a236de</gtr:id><gtr:otherNames>Gouzy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn><gtr:outcomeId>pm_14635_25_24077180</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62A094DA-BECA-4386-AD18-42870B23CCCE</gtr:id><gtr:title>Biosynthesis and translocation of unsulfated acyltrehaloses in Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8959f30b21490711d82dead0c90d3fa7"><gtr:id>8959f30b21490711d82dead0c90d3fa7</gtr:id><gtr:otherNames>Belardinelli JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>doi_55f9869860009a9b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CA6F7A2-6B88-4115-A89C-B1DCD8DDC258</gtr:id><gtr:title>HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/567b9a23790faae26ebd0267ac4ec854"><gtr:id>567b9a23790faae26ebd0267ac4ec854</gtr:id><gtr:otherNames>Goldstone DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_14635_25_22056990</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2FA43E0-D86C-4A50-BA30-01ECB9F96E3C</gtr:id><gtr:title>Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG.</gtr:title><gtr:parentPublicationTitle>Chemistry &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/30571e1ee9e907a7155d52d34a51c2c9"><gtr:id>30571e1ee9e907a7155d52d34a51c2c9</gtr:id><gtr:otherNames>Mori G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1074-5521</gtr:issn><gtr:outcomeId>5675e7098f1e7</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UP_A253_1111</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>